Cipla Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cipla Ltd with three other
companies in this sector in India:
sales of 174.94 billion Indian Rupees [US$2.71 billion]
Dr.Reddy's Laboratories Ltd
(140.81 billion Indian Rupees [US$2.18 billion]
of which 82%
was Generics), and
Aurobindo Pharma Ltd
(150.90 billion Indian Rupees [US$2.34 billion]
Cipla Ltd reported sales of 146.30 billion Indian Rupees (US$2.27 billion)
March of 2017.
increase of 7.0%
versus 2016, when the company's sales were 136.78 billion Indian Rupees.
Sales at Cipla Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 111%).